Delivery Order SPE2DB20D3103-SPE2DB24FP6Q4

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.20 firm fixed-price delivery order covers the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.00 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product. The award has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,475.80 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a period of performance through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.55 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.10 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, with a completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is the prime contractor and holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,895.96. The award is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product, with a completion date of May 19, 2025. The contract is not set-aside and is an open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award, with ID SPE2DB20D1050|SPE2DB24FH72Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,619.10 fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product, with a completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,847.40 firm-fixed-price delivery order is for 4,557,533,935 units of Tubersol 5T (0.1 ML vial, 5 ML), a tuberculin purified protein derivative used for tuberculosis testing. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the supply of Tubersol 5T Unit/0.1 ML Vial ML. The award, valued at $1,079.40, was made by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for...
This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,285.14. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of June 25, 2025. This contract is not set-aside and is open to competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP6Q4
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,312.90 firm fixed-price contract is for the supply of Tubersol 5T Unit/0.1 ML Vial 5ML, a pharmaceutical product.

The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. In addition to the DLA, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:23 AM